Brief: BRIEF TEMPLATE

Sandoz AG

05/11/2025 06:29

Corrects the value in the headline, adds missing part on royalties

Nov 5 (Reuters) - EVOTEC SE EVTG.DE:

SAID ON TUESDAY: EVOTEC SIGNS AGREEMENT WITH SANDOZ

RESULTING IN PAYMENTS POTENTIALLY OVER US$ 650 MLN PLUS ROYALTIES

AGREEMENT INCLUDES APPROXIMATELY US$ 350 MLN IN CASH FOR JUST – EVOTEC BIOLOGICS MANUFACTURING SITE IN TOULOUSE AND UPFRONT TECHNOLOGY LICENSE FEES TO EVOTEC'S CONTINUOUS MANUFACTURING PLATFORM

TRANSACTION COVERING ROYALTIES ON A PORTFOLIO OF UP TO TEN BIOSIMILARS IN TECHNICAL AND EARLY DEVELOPMENT TARGETING MORE THAN US$ 90 BLN OF ORIGINATOR NET SALES

SALE IMMEDIATELY EARNINGS ACCRETIVE, IMPROVING EVOTEC'S SHORT, MID AND LONG-TERM REVENUE MIX, PROFIT MARGINS, AND CAPITAL EFFICIENCY

THE CONTRACT SIGNATURE FOLLOWS THE ANNOUNCEMENT IN JULY OF A NON-BINDING TERM-SHEET AGREEMENT ON 30 JULY 2025

BOTH PARTIES AIM TO CLOSE THE TRANSACTION IN Q4 2025 SUBJECT TO MEETING CLOSING CONDITIONS INCLUDING FOREIGN DIRECT INVESTMENT (FDI) CLEARANCE BY THE FRENCH AUTHORITIES

Further company coverage: [EVTG.DE]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))